Literature DB >> 7389156

Twenty-four hour profiles of serum prolactin during male puberty with and without gynaecomastia.

D M Large, D C Anderson, I Laing.   

Abstract

Twenty-four hour profiles of circulating prolactin have been documented in eight boys with simple delayed puberty, eleven with gynaecomastia, three of whom were retested following its spontaneous resolution, and two normal adult men. Mean 24 h prolactin levels in four boys with delayed puberty and ten with gynaecomastia exceeded the mean levels for the two adult men. A sleep-associated rise in prolactin levels occurred at all stages of puberty irrespective of the presence or absence of gynaecomastia, and in some subjects peaks also occurred during the daytime. Boys with gynaecomastia had higher 24 h means levels of prolactin (P less than 0.05), higher daytime levels (P less than 0.05) and higher sleep-associated levels (P less than 0.05) than did control subjects. These were not related to the degree or duration of the gynaecomastia, but 24 h mean levels of prolactin and oestradiol were positively correlated. In one subject who had had transient galactorrhoea, high levels of circulating prolactin, oestrone and oestradiol fell following spontaneous resolution of the gynaecomastia. We believe that oestrogen: androgen imbalance during the daytime is the major cause of pubertal gynaecomastia, with hyperprolacinaemia (which may cause galactorrhoea) sometimes occurring as a response to relative hyperoestrogenaemia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389156     DOI: 10.1111/j.1365-2265.1980.tb02713.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  2 in total

1.  Normoprolactinemia in boys with marked gynecomastia.

Authors:  W Beck
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

2.  Sexual maturation of the hypothalamus: pathophysiological aspects and clinical implications.

Authors:  M G Forest
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.